SCARTONI, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 174
EU - Europa 84
AS - Asia 44
Totale 302
Nazione #
US - Stati Uniti d'America 172
IT - Italia 36
CN - Cina 17
IE - Irlanda 17
HK - Hong Kong 16
SE - Svezia 12
DE - Germania 7
JO - Giordania 5
SG - Singapore 5
FI - Finlandia 4
RU - Federazione Russa 4
CA - Canada 2
FR - Francia 2
CH - Svizzera 1
CZ - Repubblica Ceca 1
KR - Corea 1
Totale 302
Città #
Fairfield 21
Chandler 20
Dublin 17
Ashburn 14
Hong Kong 12
Woodbridge 11
Altamura 8
Beijing 8
Houston 8
Lawrence 8
Princeton 8
Seattle 8
Cambridge 7
Dearborn 6
Florence 6
New York 6
Wilmington 6
Buffalo 4
Rome 4
Boston 3
Munich 3
Boardman 2
Fiesole 2
Medford 2
Nantes 2
Palombara Sabina 2
Shanghai 2
Toronto 2
Wuxi 2
Ann Arbor 1
Bari 1
Bern 1
Guangzhou 1
Hebei 1
Hefei 1
Hillsboro 1
Kent 1
Montemurlo 1
Nanjing 1
Norwalk 1
Quzhou 1
Redwood City 1
Seoul 1
Singapore 1
Vercelli 1
Totale 220
Nome #
91P * DEFINITIVE CONCOMITANT RADIOCHEMOTHERAPY (RCT) TREATMENT FOR LOCALLY ADVANCED (LA) NON SMALL CELL LUNG CANCER (NSCLC): EVALUATION OF HEMATOLOGICAL AND ESOPHAGEAL TOXICITY IN THE RADIATION ONCOLOGY DEPARTMENT OF UNIVERSITY OF FLORENCE EXPERIENCE 88
Oral Lapacho-Based Medication: An Easy, Safe, and Feasible Support to Prevent and/or Reduce Oral Mucositis during Radiotherapy for Head and Neck Cancer 85
Nutritional Supplement Based on Zinc, Prebiotics, Probiotics and Vitamins to Prevent Radiation-related Gastrointestinal Disorders 58
Protective Effect of Leuprorelin on Radiation-induced Intestinal Toxicity 44
Lobectomy vs Stereotactic Ablative Radiotherapy in NSCLC: a multicentric series in four centers 22
Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review 19
Totale 316
Categoria #
all - tutte 1.445
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.445


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202054 4 2 1 3 6 7 7 7 5 4 5 3
2020/202113 1 3 0 4 1 0 0 1 1 1 1 0
2021/202222 0 3 0 1 2 0 1 2 1 1 4 7
2022/2023114 10 27 3 4 10 15 10 6 12 0 2 15
2023/202449 1 6 7 2 4 11 0 13 2 0 2 1
2024/20258 8 0 0 0 0 0 0 0 0 0 0 0
Totale 316